Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease
- 31 May 2005
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (4), 329-335
- https://doi.org/10.1016/j.nucmedbio.2005.01.006
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 22 references indexed in Scilit:
- Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging AgentsJournal of Medicinal Chemistry, 2003
- Structure−Activity Relationship of Imidazo[1,2-a]pyridines as Ligands for Detecting β-Amyloid Plaques in the BrainJournal of Medicinal Chemistry, 2002
- Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red DerivativeJournal of Neuropathology and Experimental Neurology, 2002
- A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brainBioorganic & Medicinal Chemistry Letters, 2001
- IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brainNuclear Medicine and Biology, 2001
- Radioiodinated Styrylbenzenes and Thioflavins as Probes for Amyloid AggregatesJournal of Medicinal Chemistry, 2001
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Imaging Alzheimer's amyloidNature Biotechnology, 2000
- In vivo detection of amyloid plaques in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2000
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995